Highlights
NASDAQ: SGNL       Signal Genetics Cmn
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:0.12 - 17.74
52 Weeks Price Volatility (%):
0.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

miRagen Therapeutics Inc., formerly Signal Genetics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of micro-ribonucleic acid (RNA)-targeted therapies. Its lead product candidates, MRG-106 and MRG-201, are in Phase I clinical trials. Its therapeutic areas of focus include cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Its clinical product candidate for the treatment of certain cancers, MRG-106, is an inhibitor of microRNA-155, which is found at abnormally high levels in several blood cancers. The Company's clinical product candidate for the treatment of pathological fibrosis, MRG-201, is a replacement for miR-29, which is found at abnormally low levels in a range of pathological fibrotic conditions, including cardiac, renal, hepatic and pulmonary fibrosis, as well as systemic sclerosis. In addition to its clinical programs, it is developing a pipeline of pre-clinical product candidates.

  Be the first to like this.
 


 

2913  4314  780  431 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 TRXC 2.81+1.35 
 BAC 26.24+0.41 
 GE 23.36+0.38 
 GDX 23.46-0.38 
 RAD 1.86+0.12 
 XLF 26.30+0.17 
 VALE 10.50+0.05 
 PCG 53.43-4.29 
 SPY 255.29+0.34 
 AMD 14.26+0.04 
Partners & Brokers